What I find strange is the repeated attempts to sh
Post# of 72440
Didn't R only increase the effectiveness of B by about 1%?
I am not saying it is nothing but close to it IMO when R alone showed no effectiveness at all in reducing the mortality rate.
Maybe R is better than I characterize it (IMO it is basically a POS) but that is just what I have come to believe when looking at the cost and then at what it can do.
I am against it mainly because the cost added to B would cut down greatly on a worldwide scale IMO how many patients could get it.